ERBB2 and breast carcinoma: Genistein is indicated to inhibit growth of ER+ and HER-2+ breast cancer cells, delay onset of spontaneous mammary tumors in MMTV-neu mouse model, induce cellular differentiation, and inhibit cell cycle progression in ER+ and HER-2+ breast cancer cells [30–35].